Impact of COVID-19 on Melanoma Patients' Well-Being
Well-Being and Quality of Life in Melanoma Patients During COVID-19 Pandemic
M.D. Anderson Cancer Center · NCT04474301
This study looks at how the COVID-19 pandemic has impacted the mental health and quality of life of people with melanoma.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1152 (estimated) |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center (other) |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT04474301 on ClinicalTrials.gov |
What this trial studies
This observational study aims to understand how the COVID-19 pandemic has affected the health-related quality of life and psychological well-being of melanoma patients. It will assess various experiences during the pandemic, including psychological distress, healthcare disruptions, and social interactions. Participants will complete a 10-minute questionnaire that connects their COVID-19 experiences with prior lifestyle data collected in a previous protocol. The study also seeks to evaluate the role of resiliency factors, such as social support, in moderating these effects.
Who should consider this trial
Good fit: Ideal candidates are melanoma patients who have previously consented to protocol PA15-0336 and can be contacted via MyChart.
Not a fit: Patients who have not consented to protocol PA15-0336 or lack an active email address may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how to better support melanoma patients during crises like the COVID-19 pandemic.
How similar studies have performed: While studies have explored the impact of pandemics on health-related quality of life, this specific approach focusing on melanoma patients during COVID-19 is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients who have signed consent for PA15-0336 * Has an active email address and can be contacted via MyChart * Documentation of being alive per the cancer registry
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (RECRUITING)
Study contacts
- Principal investigator: Lorenzo Cohen — M.D. Anderson Cancer Center
- Study coordinator: Lorenzo Cohen
- Email: lcohen@mdanderson.org
- Phone: (713) 745-4260
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COVID-19 Infection, Melanoma